Faster Cholinergic REM Sleep Induction in Euthymic Patients with Primary Affective Illness
- 11 April 1980
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 208 (4440) , 200-202
- https://doi.org/10.1126/science.7361118
Abstract
Arecoline, a cholinergic muscarinic receptor agonist, induced rapid eye movement sleep significantly more rapidly in patients with primary affective illness in remission than in normal control subjects matched for age and sex. These results, and others, suggest that patients with primary affective illness may have a supersensitive cholinergic system both when they are ill and when their symptoms are in clinical remission.Keywords
This publication has 13 references indexed in Scilit:
- Muscarinic supersensitivity: A possible model for the sleep disturbance of primary depression?Psychiatry Research, 1979
- Scopolamine-induced muscarinic supersensitivity in normal man: Changes in sleepPsychiatry Research, 1979
- Blindness and Reliability in Lifetime Psychiatric DiagnosisArchives of General Psychiatry, 1979
- Some Observations on the Opiate Peptides and SchizophreniaArchives of General Psychiatry, 1979
- Experimental acceleration and slowing of REM sleep ultradian rhythm by cholinergic agonist and antagonistNature, 1978
- The Neuropharmacology of Sleep and WakefulnessAnnual Review of Pharmacology and Toxicology, 1978
- Physostigmine in ManiaArchives of General Psychiatry, 1978
- REM Sleep Induction by Physostigmine Infusion During SleepScience, 1976
- Physostigmine: Effects on cognition and affect in normal subjectsPsychopharmacology, 1976
- Parasympathetic Suppression of Manic Symptoms by PhysostigmineArchives of General Psychiatry, 1973